Edition:
United States

Pfizer Inc (PFE.N)

PFE.N on New York Stock Exchange

32.05USD
4:00pm EDT
Change (% chg)

$-0.09 (-0.28%)
Prev Close
$32.14
Open
$32.20
Day's High
$32.28
Day's Low
$31.98
Volume
7,575,559
Avg. Vol
6,578,655
52-wk High
$37.39
52-wk Low
$29.83

Latest Key Developments (Source: Significant Developments)

Pfizer recommends shareholders reject below-market mini-tender offer by TRC Capital
6:45am EDT 

May 24 (Reuters) - Pfizer Inc :Pfizer recommends shareholders reject the below-market mini-tender offer by TRC Capital Corporation.Pfizer - received notice of unsolicited mini-tender offer by TRC Capital to purchase up to 4 million shares of Pfizer common stock at $31.60 per share in cash.Says TRC Capital's offer price of $31.60 per share is about 4.27 percent lower than $33.01 closing share price on may 12.Pfizer Inc - TRC Capital's offer is for approximately 0.067 percent of shares of Pfizer common stock outstanding as of may 15, 2017 offer date.Says "Pfizer does not endorse trc capital's unsolicited mini-tender offer".  Full Article

Sangamo receives fast track designation from FDA for SB-525
Tuesday, 16 May 2017 07:30am EDT 

May 16 (Reuters) - Pfizer Inc -:Sangamo receives fast track designation from the FDA for sb-525 investigational hemophilia a gene therapy.Sangamo Therapeutics Inc says data from phase 1/2 clinical trial evaluating sb-525 in adults with hemophilia a expected in late 2017 or early 2018.  Full Article

Soros Fund Management more than triples share stake in Microsoft, takes share stake in Snap, Alibaba
Monday, 15 May 2017 05:34pm EDT 

May 15 (Reuters) - Soros Fund Management::Takes share stake in Alibaba of 107,200 ADRs - SEC filing.Dissloves share stake in Amazon.com Inc.Takes share stake of 9,900 shares in Chevron.More than triples share stake in Microsoft to 12,800 shares.Ups share stake in Goldman Sachs Group Inc by 39.8 percent to 86,800 shares.Takes share stake of 3,600 shares in Walt Disney Co.Takes share stake of 31,200 shares in Pfizer Inc.Takes share stake of 1.7 million class A shares in Snap Inc.Takes share stake of 4,100 shares in Wal-Mart Stores Inc.Change in holdings are as of March 31, 2017 and compared with the previous quarter ended as of Dec. 31, 2016.  Full Article

Pfizer says in connection with Hospira acquisition, expects to incur costs of about $1 bln for up to 3-yr period post-acquisition
Thursday, 11 May 2017 04:43pm EDT 

May 11 (Reuters) - Pfizer Inc ::Pfizer says in connection with Hospira acquisition, expects to incur costs of about $1 billion for up to three-year period post-acquisition-sec filing.Pfizer says in early 2017, initiated new enterprise-wide cost reduction/productivity initiatives, which expect to complete by end of 2019.Pfizer says 2017 cost reduction/productivity initiatives includes optimization of manufacturing plant network to support IH and EH products and pipelines.Pfizer says during 2017-2019, expects to incur costs of about $750 million related to cost reduction initiatives.  Full Article

Sangamo Therapeutics and Pfizer announce collaboration for Hemophilia A gene therapy
Wednesday, 10 May 2017 04:01pm EDT 

May 10 (Reuters) - Pfizer Inc :Sangamo Therapeutics and Pfizer announce collaboration for Hemophilia A gene therapy.Sangamo Therapeutics Inc says under terms of collaboration agreement, Sangamo will receive a $70 million upfront payment from Pfizer.Sangamo Therapeutics Inc says Sangamo will be responsible for conducting SB-525 phase 1/2 clinical study and certain manufacturing activities.Sangamo -Pfizer will be operationally and financially responsible for subsequent research, development, manufacturing and commercialization activities for SB-525.Sangamo Therapeutics Inc says Sangamo is eligible to receive potential milestone payments of up to $475 million.Sangamo Therapeutics Inc says Sangamo will also receive tiered double-digit royalties on net sales.Sangamo Therapeutics Inc says additionally, Sangamo will be collaborating with Pfizer on manufacturing and technical operations utilizing viral delivery vectors.  Full Article

U.S. FDA grants accelerated approval to Avelumab for Urothelial Carcinoma
Tuesday, 9 May 2017 12:22pm EDT 

May 9 (Reuters) - U.S. FDA::U.S. Food and Drug Administration grants accelerated approval to avelumab for urothelial carcinoma.  Full Article

Pfizer says multi-year extension of collaboration with Bill & Melinda Gates Foundation, Children's Investment Fund Foundation
Monday, 8 May 2017 10:00am EDT 

May 8 (Reuters) - Pfizer Inc ::Co, the Bill & Melinda Gates Foundation, Children's Investment Fund Foundation announced multi-year extension of collaboration.Pfizer Inc., Bill & Melinda Gates Foundation, and Children's Investment Fund Foundation reduce price of injectable contraceptive.Sayana Press will now be available to qualified purchasers at guaranteed price of $0.85 per dose, reduction from previous price of $1.00/dose.  Full Article

Pfizer announces U.S. FDA filing acceptance of supplemental new drug application for Xeljanz
Wednesday, 3 May 2017 09:00am EDT 

May 3 (Reuters) - Pfizer Inc :Pfizer announces U.S. FDA filing acceptance of supplemental new drug application for Xeljanz (tofacitinib citrate) for the treatment of adult patients with active psoriatic arthritis.FDA has provided an anticipated prescription drug user fee act (PDUFA) action date in December 2017 for SNDAS.Both studies met primary endpoints showing statistically significant improvement with Xeljanz 5 mg,10 mg bid compared to placebo treatment.A separate SNDA was also accepted for Xeljanz XR extended release 11 mg once daily use in PSA.  Full Article

Pfizer Q1 adjusted earnings per share $0.69
Tuesday, 2 May 2017 06:45am EDT 

May 2 (Reuters) - Pfizer Inc :Pfizer reports first-quarter 2017 results.Pfizer inc - reaffirmed 2017 financial guidance.Q1 adjusted earnings per share $0.69.Q1 earnings per share $0.51.Reaffirmed 2017 financial guidance.Q1 earnings per share view $0.67 -- Thomson Reuters I/B/E/S.Pfizer inc - q1 revenue $12,779 million versus $13,005 million.Q1 revenue view $13.09 billion -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $2.55, revenue view $53.15 billion -- Thomson Reuters I/B/E/S.Pfizer inc - q1 innovative health segement revenue $7,415 million versus $7,033 million.Pfizer inc - as of may 2, 2017, pfizer's remaining share repurchase authorization was approximately $6.4 billion.Pfizer inc - qtrly worldwide total lyrica revenue $1,271 million versus $1,229 million.Pfizer inc- qtrly worldwide ibrance revenue $679 million versus $429 million.Pfizer inc - q1 worldwide lipitor revenue $404 million versus $411 million.Pfizer inc - q1 worldwide prevnar family revenue $1,392 million versus $1,509 million.Pfizer -there was one less selling day in u.s. And 2 fewer selling days in international markets during q1, resulting in negative impact of about $300 million in q1.  Full Article

Pfizer Inc declared a 32-cent Q2 2017 dividend on co's common stock
Thursday, 27 Apr 2017 12:30pm EDT 

April 27 (Reuters) - Pfizer Inc ::Declared a 32-cent second-quarter 2017 dividend on company's common stock.  Full Article

More From Around the Web

Pfizer must face Lipitor injury lawsuits in California state court - judge

Pfizer Inc has lost a bid to remove from California state to federal court lawsuits by about 4,800 women who claim they developed diabetes as a result of taking the blockbuster anti-cholesterol drug Lipitor.